This article was created in collaboration with Our Cancer Stories by Polya Genova and is intended for educational purposes.
Our Cancer Stories is an online platform dedicated to supporting the cancer community through medically reviewed articles and a global collection of real patient stories. It aims to support patients and caregivers at every stage of the cancer journey, helping them feel more informed, supported, and less alone.
→ Visit their website and learn about their work.
The tiny pollinators quietly supporting the future of cancer research
On May 20th, we celebrated World Bee Day. World Bee Day is a global initiative led by the Food and Agriculture Organization of the United Nations to raise awareness of the vital role bees and other pollinators play in sustaining ecosystems, food security, and biodiversity. The date honors the birthday of Anton Janša (1734–1773) who was a pioneer of modern beekeeping whose work helped shape our understanding of these remarkable insects.
This year's theme, "A partnership that sustains us all" highlights the interconnected relationship between humans and bees and reminds us that our wellbeing depends on the health of the natural world. As human activities continue to reshape landscapes and threaten habitats, protecting pollinators is a necessity for our collective future.
When most people think about the importance of bees, pollination is the first thing that comes to mind and for good reason. Bees are responsible for pollinating a significant proportion of the world's crops and wild plants, making them essential to healthy ecosystems and global food production. However, their contributions extend far beyond agriculture. In recent years, scientists have increasingly turned their attention to bees and bee-derived products for their potential applications in medicine. From compounds found in bee venom to the unique properties of honey and propolis, the tiny pollinators are helping researchers explore new approaches to disease prevention, treatment, and drug development.
Among the most promising areas of investigation is cancer research. Below, we explore the ways bees are supporting and influencing advances in cancer science.
1. Buckwheat honey
Honey is increasingly being explored in cancer research as a general supportive supplement, as well as for its potential role in prevention. In laboratory settings, honey has been shown to interfere with the uncontrolled growth of abnormal cells, slow their ability to multiply, and even trigger the body's natural "self-destruct" mechanism for damaged cells. Some studies suggest honey may affect cancer cells more strongly than healthy ones, and it appears to act across several interconnected pathways involved in cancer development, including inflammation, oxidative stress, and key cell signaling systems that regulate growth and survival.
It's also becoming clear that not all honey is biologically the same. Its effects can vary significantly depending on floral source, geography, and how it is processed, all of which shape its chemical profile. In general, darker honeys tend to show stronger effects in lab research because they contain higher levels of antioxidants and plant compounds called polyphenols. These are natural substances found in plants that can help protect cells from damage. Buckwheat honey is often highlighted because it is especially rich in these compounds, and in some lab studies it has shown stronger effects on slowing the growth of cancer cells compared to lighter honeys. Other well-studied types like Manuka, Tualang, and certain chestnut honeys have also shown promising results, which may be linked to their unique natural chemical makeup.
2. Melittin (bee venom peptide)
Melittin, a peptide found in bee venom, has shown in early laboratory research the ability to interact with and disrupt certain cancer cell membranes, making it an active area of experimental oncology research. Melittin seems to have the ability to interact directly with cell membranes, which is important as cancer cells, unlike normal cells, often have altered membrane structures and signaling pathways, which can make them more vulnerable to this type of disruption.
In laboratory studies, melittin has been shown to damage cancer cells by creating pores in their outer membranes, compromising cell integrity and triggering cell death. It can also activate internal stress pathways that lead to apoptosis, the process by which the body removes damaged or abnormal cells. Across multiple experimental studies, melittin has demonstrated strong anticancer activity in different cancer cell lines by reducing cell viability, inhibiting proliferation, and promoting programmed cell death. However, these findings remain largely preclinical, and its effects in clinical settings are still under investigation. Because of its high potency, melittin may also affect healthy cells if not carefully controlled, which highlights important safety considerations for its potential therapeutic use.
3. Propolis and immune system research
Propolis, sometimes called "bee glue," is a resin-like substance that bees produce by mixing plant resins with wax and enzymes to seal and protect their hives. In cancer research, propolis has attracted attention because it appears to act on several of the key processes involved in how cancer develops and spreads. In laboratory studies, extracts of propolis and its isolated compounds have been shown to slow the uncontrolled growth of cancer cells, interfere with their ability to divide, and trigger programmed cell death (apoptosis).
Research also suggests that propolis may reduce the formation of new blood vessels that tumors need in order to grow and spread, and may limit processes involved in metastasis, where cancer cells move to other parts of the body. In addition, there is emerging evidence that it may help cancer cells become more sensitive to chemotherapy, potentially improving treatment effectiveness in experimental settings.
It is important to note that most of this evidence comes from cell and animal studies rather than human trials. This means propolis is not a proven cancer treatment, but rather a promising area of ongoing research. Its complex and variable composition also makes it difficult to standardize, since its biological effects depend heavily on its botanical source and extraction method.
Bees, Bioactive Compounds, and the Bigger Picture
Across honey, bee venom, and propolis, it emerges that bees produce a remarkably diverse range of bioactive substances that are now being explored in modern biomedical research. While these three bee-derived products differ in origin and composition, each contains compounds that can influence fundamental biological processes such as inflammation, oxidative stress, cell signalling, and programmed cell death. Taken together, these examples illustrate an important shift in how science views natural products as complex chemical systems that can help reveal new mechanisms, inspire drug development, and potentially complement existing treatments. However, the research is still largely at the experimental stage, and significant challenges remain in terms of safety, standardization, and clinical validation before any of these substances can be translated into reliable therapies.
Ultimately, what connects honey, melittin, and propolis is not only their biological activity, but their origin. All three depend on bees and the landscapes they interact with. This makes their scientific value inseparable from environmental health. Protecting bees is therefore also about recognizing a deeper partnership between humans and the natural world. If we begin to truly view our coexistence with bees as "a partnership that sustains us all," we open the door to more than ecological stability. We preserve the possibility of future medical discoveries, new therapies, and scientific breakthroughs that have yet to be imagined.
References:
Al Shammari, B. A., Al Junaidi, H. S., Alasmari, M. M., et al. (2025). Bee venom and thymoquinone combination inhibits cancer cells by inducing cell cycle arrest and apoptosis. Scientific Reports, 15, 45285. https://doi.org/10.1038/s41598-025-28733-9
Altabbal, S., Athamnah, K., Rahma, A., Wali, A. F., Eid, A. H., Iratni, R., & Al Dhaheri, Y. (2023). Propolis: A detailed insight of its anticancer molecular mechanisms. Pharmaceuticals, 16(3), 450. https://doi.org/10.3390/ph16030450
Bindlish, A., & Sawal, A. (2024). Bee sting venom as a viable therapy for breast cancer: A review article. Cureus, 16(2), e54855. https://doi.org/10.7759/cureus.54855
Forma, E., & Bryś, M. (2021). Anticancer activity of propolis and its compounds. Nutrients, 13(8), 2594. https://doi.org/10.3390/nu13082594
Kmail, A. (2026). Honey and cancer: From traditional medicine to modern adjuvant therapy. Frontiers in Oncology, 16, 1745285. https://doi.org/10.3389/fonc.2026.1745285
Martinotti, S., Bonsignore, G., & Ranzato, E. (2024). Understanding the anticancer properties of honey. International Journal of Molecular Sciences, 25(21), 11724. https://doi.org/10.3390/ijms252111724